AXSM Latest Headlines

UBS Sticks to Its Buy Rating for Axsome Therapeutics (AXSM)

at www.tipranks.com (Thu, 15-Oct 11:15 AM)

Needham Keeps Their Buy Rating on Axsome Therapeutics (AXSM)

at www.tipranks.com (Thu, 15-Oct 7:36 AM)

Analysts Offer Insights on Healthcare Companies: Starling Oncology Institute (STLN), Axsome Therapeutics (AXSM) and Contineum Therapeutics, Inc. Class A (CTNM)

at www.tipranks.com (Wed, 14-Oct 7:40 AM)

Axsome’s 46% Revenue Surge Underscores Expanding CNS Franchise and Pipeline Momentum

Market Chameleon (Mon, 10-Aug 7:30 AM)